Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 78667J108 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| BlackRock, Inc. 13G/A | 7.2% |
4/17/2025
Event 3/31/2025
|
||
| Vanguard Group Inc 13G/A | 5.2% |
7/29/2025
Event 6/30/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (6) | ||||
|
RTW Investments, LP
13G/A
|
4.9% |
2/14/2025
Event 12/31/2024
|
||
| RTW Investments, LP | 4.9% | |||
| Roderick Wong, M.D. | 4.9% | |||
|
BB Biotech AG
13G/A
|
1.9% |
1/17/2025
Event 1/13/2025
|
||
| BB Biotech AG | 1.9% | |||
| Biotech Target N.V. | 1.9% | |||
|
Morgan Stanley
13G/A
|
1.6% |
3/6/2025
Event 2/28/2025
|
||
| Morgan Stanley | 1.6% | |||
| Morgan Stanley & Co. LLC | 0.3% | |||
|
FMR LLC
13G/A
|
0.8% |
3/7/2025
Event 2/28/2025
|
||
| FMR LLC | 0.8% | |||
| Abigail P. Johnson | 0.8% | |||
|
Biogen Inc.
13D/A
|
0% |
7/30/2025
Event 7/30/2025
|
||
| Biogen Inc. | 0% | |||
| Biogen MA Inc. | 0% | |||
|
Madison Avenue Partners, LP
13G/A
|
0% |
11/14/2025
Event 9/30/2025
|
||
| Madison Avenue Partners, LP | 0% | |||
| Madison Avenue International LP | 0% | |||
| EMAI Management, LLC | 0% | |||
| Madison Avenue GP, LLC | 0% | |||
| Caraway Jackson Investments LLC | 0% | |||
| Eli Samaha | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 1 | 1.00 | $9.00 |
| 2026 Q1 | 1 | 1.00 | $9.00 |
| 2025 Q4 | 2 | 22.2 k | $460 k |
| 2025 Q3 | 5 | 56.4 k | $494 k |
| 2025 Q2 | 210 | 51.9 M | $473 M |
| 2025 Q1 | 208 | 51.8 M | $412 M |
| 2024 Q4 | 186 | 51.2 M | $278 M |
| 2024 Q3 | 190 | 51.6 M | $375 M |
| 2024 Q2 | 211 | 56.1 M | $609 M |
| 2024 Q1 | 222 | 62.2 M | $1.17 B |
| 2023 Q4 | 223 | 59.1 M | $1.28 B |
| 2023 Q3 | 217 | 59.1 M | $1.22 B |
| 2023 Q2 | 251 | 54.9 M | $2.58 B |
| 2023 Q1 | 234 | 53.2 M | $2.23 B |
| 2022 Q4 | 230 | 54.4 M | $2.55 B |
| 2022 Q3 | 223 | 52.4 M | $2.05 B |
| 2022 Q2 | 228 | 51.1 M | $1.65 B |
| 2022 Q1 | 236 | 50.7 M | $1.68 B |
| 2021 Q4 | 249 | 50.4 M | $2.14 B |
| 2021 Q3 | 247 | 49.1 M | $2.17 B |
| 2021 Q2 | 288 | 50.7 M | $2.88 B |
| 2021 Q1 | 293 | 53.1 M | $3.97 B |
| 2020 Q4 | 277 | 54.2 M | $4.69 B |
| 2020 Q3 | 258 | 53.7 M | $3.28 B |
| 2020 Q2 | 247 | 54.3 M | $2.26 B |
| 2020 Q1 | 256 | 56.3 M | $1.62 B |
| 2019 Q4 | 309 | 56.6 M | $4.09 B |
| 2019 Q3 | 324 | 59.0 M | $8.30 B |
| 2019 Q2 | 317 | 58.2 M | $10.7 B |
| 2019 Q1 | 302 | 56.9 M | $9.04 B |
| 2018 Q4 | 291 | 50.2 M | $4.81 B |
| 2018 Q3 | 310 | 50.4 M | $7.12 B |
| 2018 Q2 | 295 | 48.8 M | $7.64 B |
| 2018 Q1 | 273 | 47.9 M | $7.70 B |
| 2017 Q4 | 257 | 44.1 M | $7.26 B |
| 2017 Q3 | 207 | 39.4 M | $2.46 B |
| 2017 Q2 | 224 | 38.4 M | $3.06 B |
| 2017 Q1 | 223 | 37.9 M | $2.69 B |
| 2016 Q4 | 185 | 36.9 M | $1.88 B |
| 2016 Q3 | 168 | 37.8 M | $1.74 B |
| 2016 Q2 | 170 | 30.2 M | $920 M |
| 2016 Q1 | 151 | 29.7 M | $953 M |
| 2015 Q4 | 146 | 23.6 M | $1.38 B |
| 2015 Q3 | 144 | 28.0 M | $1.20 B |
| 2015 Q2 | 131 | 26.4 M | $1.93 B |
| 2015 Q1 | 93 | 21.5 M | $1.08 B |
| 2014 Q4 | 74 | 20.3 M | $736 M |
| 2014 Q3 | 53 | 18.9 M | $596 M |